<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04863378</url>
  </required_header>
  <id_info>
    <org_study_id>00022363</org_study_id>
    <secondary_id>KL2TR002370</secondary_id>
    <nct_id>NCT04863378</nct_id>
  </id_info>
  <brief_title>Efficacy of a Multimodal Brain Health Intervention for Older African Americans</brief_title>
  <acronym>SHARP</acronym>
  <official_title>Efficacy of a Technology-Based Multimodal Brain Health Intervention for Older African Americans: The SHARP Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Advancing Translational Science (NCATS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Clinical and Translational Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rush University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study tests the feasibility, acceptability, and efficacy of a multimodal intervention&#xD;
      (walking, social engagement, and reminiscence), including the use of wearable digital&#xD;
      biomarkers, for cognitively healthy and mildly cognitively impaired African Americans aged 65&#xD;
      and older.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cognitively healthy and mildly cognitively impaired participants engage in 16 weeks of&#xD;
      triadic neighborhood walking using a group tablet device to access pre-programmed 1-mile&#xD;
      routes. GPS (Global Positioning System)-triggered historical images of local Black culture&#xD;
      and history along the route prompt conversational reminiscence about Portland, Oregon's&#xD;
      historically Black neighborhoods. Digital biomarker technology (a continuously worn actigraph&#xD;
      watch and an unobtrusive under-the-mattress sleep sensor) and weekly online surveys via a&#xD;
      study Chromebook assess feasibility, acceptability, efficacy, and health outcomes.&#xD;
      Intermittent discussions and check-ins with participants, and observational sessions will be&#xD;
      used to elicit participant feedback.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in daily activity time recorded by actigraphy watch</measure>
    <time_frame>16 weeks</time_frame>
    <description>A continuously worn actigraphy watch (Withings) measures 24-hour activity (gross motor activity).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in sleep time recorded by actigraphy watch and Emfit QS sleep sensor</measure>
    <time_frame>16 weeks</time_frame>
    <description>Actigraphy watch and Emfit QS under-the-mattress sleep sensor measure sleep-wake cycles per 24-hour period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in sleep movement recorded by Emfit QS sleep sensor</measure>
    <time_frame>16 weeks</time_frame>
    <description>An Emfit QS sleep sensor measures movement activity in bed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in weight recorded by digital scale and by Emfit QS sleep sensor</measure>
    <time_frame>16 weeks</time_frame>
    <description>A digital scale and Emfit QS sleep sensor measure weight.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in global cognition</measure>
    <time_frame>16 weeks</time_frame>
    <description>Global cognitive function measured by the Montreal Cognitive Assessment total score (MoCA total score). Montreal Cognitive Assessment is a neuropsychological test. Total score ranges from 0 to 30. Higher scores indicate better cognitive function.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Cognitive Impairment, Mild</condition>
  <condition>Cognitive Decline</condition>
  <arm_group>
    <arm_group_label>Walkers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Walkers continuously wear an actigraph watch to assess activity level. Daily sleep behavior is captured on an under-the-mattress sleep sensor. Participants walk 1-mile routes in triads, three times a week for 16 weeks while engaging in prompted conversational reminiscence recorded for a digital archive.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Walking conversational reminiscence</intervention_name>
    <description>Triadic walking with prompted conversational reminiscence</description>
    <arm_group_label>Walkers</arm_group_label>
    <other_name>SHARP: Sharing History through Active Reminiscence and Photo-imagery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Self-identified African American,&#xD;
&#xD;
          2. Age &gt; 65 years old&#xD;
&#xD;
          3. Reside or resided for &gt;10 years in Portland's historically Black neighborhoods (to be&#xD;
             familiar with Memory Markers about this area),&#xD;
&#xD;
          4. Able to ambulate independently.&#xD;
&#xD;
          5. Meeting Cognition Criteria&#xD;
&#xD;
               1. Participants with MCI (Mild Cognitive Impairment) will meet criteria consistent&#xD;
                  with the criteria outlined by the NIA-Alzheimer's Association workgroup&#xD;
&#xD;
               2. Participants without cognitive impairment will have a Montreal Cognitive&#xD;
                  Assessment (MoCA) score &gt; 24 (and not meet MCI criteria). Participants' cognitive&#xD;
                  function should allow them to get to and from walk locations independently or&#xD;
                  with minimal assistance.&#xD;
&#xD;
          6. Cognitive function allows independent (or minimally assisted) travel to and from walk&#xD;
             locations&#xD;
&#xD;
          7. In-home reliable broadband internet (for weekly online surveys).&#xD;
&#xD;
          8. Ability to read, speak, and understand English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Self-reported or clinically diagnosed dementia&#xD;
&#xD;
          2. Significant disease of the central nervous system&#xD;
&#xD;
          3. Severely depressed (CES-D score &gt; 16), significantly symptomatic psychiatric disorder&#xD;
&#xD;
          4. Advanced cardiovascular disease that would make walking difficult, including history&#xD;
             of congestive heart failure&#xD;
&#xD;
          5. Unstable insulin-dependent diabetes mellitus, received diagnosis Type 1 Diabetes,&#xD;
             started insulin within past 3 months, hospitalized for hypoglycemia within past 6&#xD;
             months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raina Croff, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrice Fuller, BS</last_name>
    <phone>503-505-4670</phone>
    <email>fullerp@ohsu.edu</email>
  </overall_contact>
  <reference>
    <citation>Croff RL, Witter Iv P, Walker ML, Francois E, Quinn C, Riley TC, Sharma NF, Kaye JA. Things Are Changing so Fast: Integrative Technology for Preserving Cognitive Health and Community History. Gerontologist. 2019 Jan 9;59(1):147-157. doi: 10.1093/geront/gny069.</citation>
    <PMID>29961887</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 21, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Raina Croff</investigator_full_name>
    <investigator_title>Co-Investigator</investigator_title>
  </responsible_party>
  <keyword>social engagement</keyword>
  <keyword>neighborhood walking</keyword>
  <keyword>reminiscence</keyword>
  <keyword>physical activity</keyword>
  <keyword>African American</keyword>
  <keyword>Mild cognitive impairment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

